Related Experiment Video
Updated: Dec 14, 2025

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
α-synuclein strains that cause distinct pathologies differentially inhibit proteasome
Genjiro Suzuki1, Sei Imura1,2, Masato Hosokawa1
1Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Different strains of alpha-synuclein (α-synuclein) aggregates cause distinct pathologies by affecting proteasome activity. This study reveals how α-synuclein aggregate structure influences disease mechanisms.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Abnormal alpha-synuclein aggregation is linked to various diseases and spreads similarly to prions.
- The relationship between prion strain structure and disease phenotype is known, but α-synuclein strain-specific pathologies remain unclear.
Purpose of the Study:
- To investigate if different α-synuclein aggregate strains cause distinct pathologies.
- To explore the seeding and propagation abilities of two α-synuclein fibril types in vivo and in vitro.
Main Methods:
- Generation of two distinct α-synuclein fibril strains from identical monomers.
- Seeding and propagation studies in mice and primary-cultured neurons.
- Analysis of protein aggregation, proteasome activity, and protein complex co-precipitation.
Main Results:
- Two α-synuclein strains were successfully generated, differing in their ability to induce phosphorylated and ubiquitinated aggregates.
- One α-synuclein strain inhibited proteasome activity and co-precipitated with the 26S proteasome complex.
- Structural differences in the C-terminal region of α-synuclein strains correlated with varying effects on proteasome activity.
Conclusions:
- Structural variations in α-synuclein aggregates (strains) can lead to distinct pathological outcomes.
- α-synuclein strains differentially impact cellular proteasome function, offering a molecular mechanism for varied pathologies.
- This research provides insights into the pathogenesis of α-synucleinopathies.
More Related Videos
09:27Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Lysosomal Hydrolases
Neural Regulation